🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

UnitedHealth (UNH) Poised To Beat On Q1 Earnings: Here's Why

Published 04/16/2017, 09:02 PM
Updated 07/09/2023, 06:31 AM
US500
-
ELV
-
UNH
-
MDCO_old
-
PRAH
-

We expect UnitedHealth Group Inc. (NYSE:UNH) to beat earnings expectations when it reports first-quarter results on Apr 18, before the opening bell.

Why a Likely Positive Surprise?

Our proven model shows that UnitedHealth has the right combination of the two key ingredients to beat on earnings.

Zacks ESP: Earnings ESP, which represents the difference between the Most Accurate estimate and the Zacks Consensus Estimate, stands at +0.46%. This is a key indicator of a likely positive earnings surprise for the company. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter .

Zacks Rank: UnitedHealth carries a Zacks Rank #2 (Buy). Note that stocks with a Zacks Rank #1 (Strong Buy), 2 or 3 (Hold) have a significantly higher chance of beating estimates.

Factors to Influence Q1 Results

We expect the quarter’s results to show health care premium increase backed by higher contribution from Medicare, Medicaid and Commercial insurance businesses. Revenues will reap the benefits of an increase in enrollment from international business, Medicare Advantage, Administrative Services Only and Commercial health insurance plans.

Results should also show an increase in revenues from its health services segment Optum. This increase is likely to be driven by higher contribution from subsegments Optum Health and OptumInsight. However, an expected decline in revenue from yet another subsegment OptumRx due to the anticipated Catamaran customer losses will to some extent offset top-line growth.

The company will also be shielded from the losses caused by the public exchange business, since it reduced its participation on the exchanges from 34 to merely three in 2017.

The company’s bottom line will be cushioned by cost control initiatives and capital management by way of share buyback.

Other Stocks That Warrant a Look

Here are some companies from the health care sector that you may also consider as our model shows that these have the right combination of elements to post an earnings beat this quarter:

Pra Health Sciences Inc. (NASDAQ:PRAH) is expected to report first-quarter earnings results on Apr 26. The company has an Earnings ESP of +1.72% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Medicines Company (NASDAQ:MDCO) has an Earnings ESP of +8.85% and a Zacks Rank #3. The company is expected to report first-quarter earnings results on Apr 26.

Anthem Inc. (NYSE:ANTM) has an Earnings ESP of +7.67% and a Zacks Rank #2. The company will report first-quarter earnings results on Apr 26.

Sell These Stocks. Now.

Just released, today's 220 Zacks Rank #5 Strong Sells demand urgent attention. If any are lurking in your portfolio or Watch List, they should be removed immediately. These are sinister companies because many appear to be sound investments. However, from 1988 through 2016, stocks from our Strong Sell list have actually performed 6X worse than the S&P 500. See today's Zacks "Strong Sells" absolutely free >>



The Medicines Company (MDCO): Free Stock Analysis Report

UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

Anthem, Inc. (ANTM): Free Stock Analysis Report

PRA Health Sciences, Inc. (PRAH): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.